CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
100 hedge funds and large institutions have $301M invested in Concert Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
10% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 31
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
100
Holding in Top 10
–
Calls
$332K
Puts
$25K
Top Buyers
| 1 | +$8.6M | |
| 2 | +$4.89M | |
| 3 | +$4.77M | |
| 4 |
PVI
Pura Vida Investments
New York
|
+$3.71M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$3M |
Top Sellers
| 1 | -$2.44M | |
| 2 | -$1.92M | |
| 3 | -$706K | |
| 4 |
Renaissance Technologies
New York
|
-$640K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$585K |